Ethical Issues in the Development of New Agents
- 1 May 1999
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 17 (2) , 145-153
Abstract
In the early drug development process for cancer therapy, several ethical dilemmas result from the use of cancer patients with advanced disease as the subjects of research in clinical trials studying...Keywords
This publication has 46 references indexed in Scilit:
- Shared understandings for informed consent: The relevance of psychological research on the provision of informationSocial Science & Medicine, 1996
- How reliable are relatives' retrospective reports of terminal illness? Patients' and relatives' accounts comparedSocial Science & Medicine, 1996
- IMPROVED DESIGNS FOR DOSE ESCALATION STUDIES USING PHARMACOKINETIC MEASUREMENTSStatistics in Medicine, 1996
- Research ethics committee audit: differences between committees.Journal of Medical Ethics, 1996
- Investigating a sequence of randomized phase II trials to discover promising treatmentsStatistics in Medicine, 1995
- Public Issues: The Objective Clinical Scientist Versus the Advocate: A Complex Ethical and Political Dilemma Facing Cancer Investigators and the PublicCancer Investigation, 1995
- Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer AgentsJNCI: Journal of the National Cancer Institute, 1993
- Cross-cultural differences in the care of patients with cancerGeneral Hospital Psychiatry, 1993
- Beneficence, Scientific Autonomy, and Self-Interest: Ethical Dilemmas in Clinical ResearchCambridge Quarterly of Healthcare Ethics, 1992
- Patient motivation and informed consent in a phase I study of an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1984